According to Zhang et al. (2019), elevated PLCβ3 mRNA levels correlate with poor overall survival rates in NSCLC patients, and correlates with poor prognosis in adenocarcinoma cases [62]. The gene discussed is PLCB3; the disease is non-small cell lung carcinoma.